vinces99 writes with news about a study that may account for a slowdown in air temperature rises. Following rapid warming in the late 20th century, this century has so far seen surprisingly little increase in the average temperature at the Earth's surface. More than a dozen theories have now been proposed for the so-called global warming hiatus, ranging from air pollution to volcanoes to sunspots. New research from the University of Washington shows the heat absent from the surface is plunging deep in the north and south Atlantic Ocean, and is part of a naturally occurring cycle. The study is published in Science. Subsurface ocean warming explains why global average air temperatures have flatlined since 1999, despite greenhouse gases trapping more solar heat at the Earth's surface. "Every week there's a new explanation of the hiatus," said corresponding author Ka-Kit Tung, a UW professor of applied mathematics and adjunct faculty member in atmospheric sciences. "Many of the earlier papers had necessarily focused on symptoms at the surface of the Earth, where we see many different and related phenomena. We looked at observations in the ocean to try to find the underlying cause." What they found is that a slow-moving current in the Atlantic, which carries heat between the two poles, sped up earlier this century to draw heat down almost a mile (1,500 meters). Most previous studies focused on shorter-term variability or particles that could block incoming sunlight, but they could not explain the massive amount of heat missing for more than a decade.
Check out the new SourceForge HTML5 internet speed test! No Flash necessary and runs on all devices. ×
Zothecula writes We've been hearing a lot about the development of tiny flying sensor-equipped robots, that could be sent into areas such as disaster sites to seek out survivors or survey the damage. However, why go to the trouble of designing those robots from scratch, when there are already ready-made insects that are about the right size? That's the thinking behind research being conducted at North Carolina State University, which is aimed at converting moths into "biobots".
schwit1 writes: Managers of NASA's Space Launch System (SLS) are searching for a mission that they can propose and convince Congress to fund. "Once SLS is into the 2020s, the launch rate should see the rocket launching at least once per year, ramping up to a projected three times per year for the eventual Mars missions. However, the latter won’t be until the 2030s. With no missions manifested past the EM-2 flight, the undesirable question of just how 'slow' a launch rate would be viable for SLS and her workforce has now been asked." Meanwhile, two more Russian rocket engines were delivered yesterday, the first time that's happened since a Russian official threatened to cut off the supply. Another shipment of three engines is expected later this year. In Europe, Arianespace and the European Space Agency signed a contract today for the Ariane 5 rocket to launch 12 more of Europe’s Galileo GPS satellites on three launches. This situation really reminds me of the U.S. launch market in the 1990s, when Boeing and Lockheed Martin decided that, rather than compete with Russia and ESA for the launch market, they instead decided to rely entirely on U.S. government contracts, since those contracts didn’t really demand that they reduce their costs significantly to compete.
cranky_chemist sends this report from NPR: "Cancer simply may be here to stay. Researchers at Kiel University, the Catholic University of Croatia and other institutions discovered that hydra — tiny, coral-like polyps that emerged hundreds of millions of years ago — form tumors similar to those found in humans. Which suggests that our cells' ability to develop cancer is "an intrinsic property" that has evolved at least since then — way, way, way before we rallied our forces to try to tackle it, said Thomas Bosch, an evolutionary biologist at Kiel University who led the study, published in Nature Communications in June (abstract) To get ahead of cancer, he said, "you have to interfere with fundamental pathways. It's a web of interactions," he said. "It's very difficult to do." That's why cancer "will probably never be completely eradicated."
KentuckyFC writes: Superconductors allow current to flow with zero resistance when cooled below some critical temperature. They are the crucial ingredients in everything from high-power magnets and MRI machines to highly sensitive magnetometers and magnetic levitation devices. But one big problem is that superconductors work only at very low temperatures — the highest is around 150 kelvin (-120 degrees centigrade). So scientists would dearly love to find ways of raising this critical temperature. Now a group of physicists say they've found a promising approach: to build metamaterial superconductors that steer electrons in the same way as other metamaterials steer light to create invisibility cloaks. The inspiration for the work comes from the observation that some high temperature superconductors consist of repeated layers of conducting and dielectric structures. So the team mixed tin — a superconductor at 3.7 kelvin — with the dielectric barium titanate and found that it raised the critical temperature by 0.15 kelvin. That's the first demonstration that superconductors can be thought of as metamaterials. With this proof of principle under their belts, the next step is to look for bigger gains at higher temperatures.
sciencehabit writes: An experimental treatment against an Ebola-related virus can protect monkeys even when given up to 3 days after infection, the point at which they show the first signs of disease. The virus, known as Marburg, causes severe hemorrhagic fever—vomiting, diarrhea, and internal bleeding. In one outbreak, it killed 90% of people it infected. There are no proven treatments or vaccines against it. The new results raise hopes that the treatment might be useful for human patients even if they don't receive it until well after infection. The company that makes the compound, Tekmira, based in Burnaby, Canada, has started a human safety trial of a related drug to treat Ebola virus disease, and researchers hope that it, too, might offer protection even after a patient has started to feel ill. In other Ebola news, the two American aid workers who were infected with the virus while in Liberia have now recovered and been released from the hospital.
StartsWithABang writes It's the holy grail of modern particle physics: discovering the first smoking-gun, direct evidence for physics beyond the Standard Model. Sure, there are unanswered questions and unsolved puzzles, ranging from dark matter to the hierarchy problem to the strong-CP problem, but there's no experimental result clubbing us over the head that can't be explained with standard particle physics. That is, the physics of the Standard Model in the framework of quantum field theory. Or is there? Take a look at the evidence from the muon's magnetic moment, and see what might be the future of physics.
aarondubrow writes The National Science Foundation today announced two $10 million projects to create cloud computing testbeds — to be called "Chameleon" and "CloudLab" — that will enable the academic research community to experiment with novel cloud architectures and pursue new, architecturally-enabled applications of cloud computing. While most of the original concepts for cloud computing came from the academic research community, as clouds grew in popularity, industry drove much of the design of their architecture. Today's awards complement industry's efforts and enable academic researchers to advance cloud computing architectures that can support a new generation of innovative applications, including real-time and safety-critical applications like those used in medical devices, power grids, and transportation systems.
sciencehabit writes China's Ministry of Agriculture has decided not to renew biosafety certificates that allowed research groups to grow genetically modified (GM) rice and corn. The permits, to grow two varieties of GM rice and one transgenic corn strain, expired on 17 August. The reasoning behind the move is not clear, and it has raised questions about the future of related research in China.